Efficacy and Safety of Cerebrolysin in the Treatment of Aphasia after Acute Ischemic Stroke
Latest Information Update: 05 Apr 2023
At a glance
- Drugs FPF 1070 (Primary)
- Indications Aphasia; Ischaemic stroke
- Focus Therapeutic Use
- Acronyms ESCAS
Most Recent Events
- 03 Apr 2023 Full patient recruitment to be completed by 28/10/2022
- 02 Sep 2022 Status changed from active, no longer recruiting to completed.
- 02 Jun 2022 Status changed from recruiting to active, no longer recruiting.